Patents by Inventor David Arlen SCHAER

David Arlen SCHAER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY WITH MERESTINIB AND ANTI-PD-L1 OR ANTI-PD-1 INHIBITORS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20190269666
    Abstract: The present invention relates to a combination therapy with N-(3-fluoro-4-(1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yloxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide (merestinib, LY2801653), or a pharmaceutically acceptable salt thereof, and antibodies that bind human co-inhibitory immune checkpoints such as Programmed Death 1 Ligand 1 (PD-L1) or Programmed Death 1 (PD-1) for the treatment of various cancers.
    Type: Application
    Filed: July 21, 2017
    Publication date: September 5, 2019
    Inventors: David Arlen SCHAER, Richard A. WALGREN, Sau-Chi Betty YAN
  • COMBINATION OF PEMBROLIZUMAB AND ABEMACICLIB FOR THE TREATMENT OF CANCER
    Publication number: 20190160148
    Abstract: The present invention relates to a combination of abemaciclib and pembrolizumab and methods of using the combination to treat certain disorders, such as breast cancer and non-small cell lung cancer.
    Type: Application
    Filed: May 19, 2017
    Publication date: May 30, 2019
    Applicant: Eli Lilly and Company
    Inventors: Richard Paul BECKMANN, Colleen Michelle MOCKBEE, David Arlen SCHAER
  • COMBINATION THERAPY FOR CANCER
    Publication number: 20180291107
    Abstract: The present invention relates to the field of medicine. More particularly, the present disclosure relates to combinations of an antibody that binds colony-stimulating factor 1 receptor (CSF-IR) and an antibody that binds human programmed cell death I ligand 1 (PD-L1) and to methods of using the combination to treat cancer, and in particular solid tumors with macrophage infiltration.
    Type: Application
    Filed: November 17, 2016
    Publication date: October 11, 2018
    Inventor: David Arlen SCHAER